Larvol Delta - CanariaBio-Inc-Announces-Enrollment-Completion-of-randomized-Phase-2-study-of-Oregovomab-in-combination-with-chemotherapy-as-neoadjuvant-treatment-of-patients-with-Advanced-Ovarian-Cancer

OvaRex (oregovomab) - CanariaBio

https://www.prnewswire.com/news-releases/canariabio-inc-announces-enrollment-completion-of-randomized-phase-2-study-of-oregovomab-in-combination-with-chemotherapy-as-neo-adjuvant-treatment-of-patients-with-advanced-ovarian-cancer-302228497.html

Aug 23, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next